Perspectiva hematológica en el tratamiento de pacientes con COVID-19: rol de los tratamientos antiinflamatorios
Rev. méd. Chile
;
148(11)nov. 2020.
Article
in Spanish
| LILACS
| ID: biblio-1389242
ABSTRACT
The pathophysiology of the inflammatory profile induced by SARS-COV2 infection has similarities with conditions of immune system activation with cytokine release such as hemophagocytic syndrome and some cases of acute graft-versus-host disease. There are encouraging results of clinical studies, performed with increasingly better methodological quality, supporting the use of targeted and specific anti-inflammatory therapy in selected groups of patients with COVID-19 with severe inflammation. In this review we describe the inflammatory pathophysiology of the disease and the recent findings about its treatment.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
RNA, Viral
/
COVID-19
Limits:
Humans
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS